These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7591320)

  • 1. Thrombolytic and antithrombotic treatment in myocardial infarction: main achievements and future perspectives.
    Agnelli G
    Int J Cardiol; 1995 Aug; 49 Suppl():S77-87. PubMed ID: 7591320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.
    Metz BK; White HD; Granger CB; Simes RJ; Armstrong PW; Hirsh J; Fuster V; MacAulay CM; Califf RM; Topol EJ
    J Am Coll Cardiol; 1998 Jun; 31(7):1493-8. PubMed ID: 9626825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct thrombin inhibition and thrombolytic therapy: rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) trial.
    White HD
    Am J Cardiol; 1998 Oct; 82(8B):57P-62P. PubMed ID: 9809893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
    Simes RJ; Topol EJ; Holmes DR; White HD; Rutsch WR; Vahanian A; Simoons ML; Morris D; Betriu A; Califf RM
    Circulation; 1995 Apr; 91(7):1923-8. PubMed ID: 7895348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in antithrombotic therapy of acute myocardial infarction.
    Gensini GF; Comeglio M; Falai M
    Am Heart J; 1999 Aug; 138(2 Pt 2):S171-6. PubMed ID: 10426878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy.
    Mahaffey KW; Granger CB; Collins R; O'Connor CM; Ohman EM; Bleich SD; Col JJ; Califf RM
    Am J Cardiol; 1996 Mar; 77(8):551-6. PubMed ID: 8610601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failed thrombolysis in myocardial infarction.
    Qasim A; Chauhan A; More RS
    Int J Cardiol; 2000 Aug; 75(1):5-14. PubMed ID: 11054500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of the GUSTO trial for thrombolytic therapy.
    Van de Werf F
    Drugs; 1996 Sep; 52(3):307-12. PubMed ID: 8875125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-PA and streptokinase.
    Smith BJ
    J Accid Emerg Med; 1999 Nov; 16(6):407-11. PubMed ID: 10572811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New strategies for enhancing the speed and rate of coronary reperfusion.
    Agnelli G
    Am J Cardiol; 1993 Dec; 72(19):51G-58G. PubMed ID: 8279362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct thrombin inhibitors as adjuncts to thrombolytic therapy.
    French JK; White HD
    Curr Cardiol Rep; 1999 Sep; 1(3):184-91. PubMed ID: 10980840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Different therapeutic regimens in thrombolysis of acute myocardial infarct].
    Zeymer U; Neuhaus KL
    Z Kardiol; 1994; 83 Suppl 6():83-8. PubMed ID: 7863705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results from clinical trials on ST-elevation myocardial infarction in a historic perspective with some pathophysiological aspects.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2003 Dec; 37(6):316-23. PubMed ID: 14668180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIMI grade flow, mortality, and the GUSTO-III trial.
    Stringer KA
    Pharmacotherapy; 1998; 18(4):699-705. PubMed ID: 9692644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of new thrombolytic substances].
    Zeymer U; Neuhaus KL
    Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.